Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

CER

6 posts
NNovo Nordisk
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
Read More

Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026

  • 2026-08-05
Novo Nordisk A/S Bagsværd, Denmark, 4 August 2026 – Novo Nordisk today announced adjusted sales and adjusted operating profit…
NNovo Nordisk
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
Read More

Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook

  • 2026-08-04
Novo Nordisk A/S Bagsværd, 4 August 2026 – Financial report for the period 1 January 2026 to 30…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Novo Nordisk’s adjusted operating profit reached DKK 32,858 million in Q1 2026

  • 2026-05-09
Novo Nordisk A/S Bagsværd, Denmark, 6 May 2026 – Financial report for the period 1 January 2026 to…
NNovo Nordisk
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read More

Novo Nordisk releases 2026 sales and operating profit outlook

  • 2026-04-28
Novo Nordisk A/S Bagsværd, Denmark, 3 February 2026 – Novo Nordisk today announced sales and operating profit growth at…
NNovo Nordisk
Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
Read More

Novo Nordisk’s sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025

  • 2026-04-28
Novo Nordisk A/S Bagsværd, Denmark 3 February 2026 – Financial report for the period 1 January 2025 to…
NNovo Nordisk
Trading in Novo Nordisk shares by board members, executives and associated persons
Read More

Novo Nordisk’s sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025

  • 2026-02-08
Novo Nordisk A/S Bagsværd, Denmark 3 February 2026 – Financial report for the period 1 January 2025 to…
Denmark
www.europesays.com